Precigen Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good afternoon, and thanks for tuning into the 40th Annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst with the firm.
Our next presenting company is Precigen. And it's my pleasure to welcome Helen Sabzevari to talk to us a little bit about the company. There is a Q&A session after the presentation. So just click the icon, and I'll work in questions where appropriate.
With that, Helen, thanks very much for sharing some of your time with us to speak.
Absolutely. Thank you so much, Eric, for having us. And we are really -- it's a pleasure always for us to present at JPMorgan presentation series. So with that, what I would like to do is, today, take a few minutes to take you through the updates that we had presented over the last year and also the goals and what we are going to do in the upcoming year. With that in mind, if we move to the second slide is our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |